Calypso

Calypso's story begins with a patient. When a family member sought treatment outside of Pennsylvania – in a state where medical marijuana was legal – their founder, Samuel P. “Pat” Black, III, acknowledged the need to advocate for patients within the Commonwealth and to develop an alternative solution of relief. From this experience, Calypso Enterprises was created.

In July 2018, Calypso was awarded one of the 13 coveted Phase II Grower/Processor licenses through the Pennsylvania Medical Marijuana Program. With this exciting news, construction of a 52,000 square foot state-of-the-art facility commenced. This was no easy task during the winter months in Erie; however, with the commitment, support, and exhaustive labors from their team members and partners, Calypso established its roots.

Today, Calypso is working to create the next generation of marijuana products by continuously improving standards of operation, empowering employees, and embracing the community we serve. Through compassion, innovation and excellence, Calypso Enterprises is dedicated to providing the highest quality medical marijuana products to those in the Commonwealth who suffer from chronic conditions.